[HTML][HTML] Integrins in cancer: Emerging mechanisms and therapeutic opportunities

F Liu, Q Wu, Z Dong, K Liu - Pharmacology & therapeutics, 2023 - Elsevier
Integrins are vital surface adhesion receptors that mediate interactions between the
extracellular matrix (ECM) and cells and are essential for cell migration and the …

Src family kinases, adaptor proteins and the actin cytoskeleton in epithelial-to-mesenchymal transition

MA Ortiz, T Mikhailova, X Li, BA Porter, A Bah… - Cell Communication and …, 2021 - Springer
Over a century of scientific inquiry since the discovery of v-SRC but still no final judgement
on SRC function. However, a significant body of work has defined Src family kinases as key …

Management of metastatic clear cell renal cell carcinoma: ASCO guideline

WK Rathmell, RB Rumble… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE To provide recommendations for the management of patients with metastatic
clear cell renal cell carcinoma (ccRCC). METHODS An Expert Panel conducted a systematic …

Small molecule inhibitors targeting the cancers

GH Liu, T Chen, X Zhang, XL Ma, HS Shi - MedComm, 2022 - Wiley Online Library
Compared with traditional therapies, targeted therapy has merits in selectivity, efficacy, and
tolerability. Small molecule inhibitors are one of the primary targeted therapies for cancer …

Src family kinases as therapeutic targets in advanced solid tumors: what we have learned so far

S Martellucci, L Clementi, S Sabetta, V Mattei, L Botta… - Cancers, 2020 - mdpi.com
Src is the prototypal member of Src Family tyrosine Kinases (SFKs), a large non-receptor
kinase class that controls multiple signaling pathways in animal cells. SFKs activation is …

[HTML][HTML] Systemic treatment of renal cell cancer: A comprehensive review

A Sánchez-Gastaldo, E Kempf, AG Del Alba… - Cancer treatment …, 2017 - Elsevier
Kidney cancer represents about 5% of all new cancer diagnoses. The most common form of
kidney cancer arises from renal epithelium, named renal cell carcinoma (RCC). This entity …

Identification of lymphocyte cell-specific protein-tyrosine kinase (LCK) as a driver for invasion and migration of oral cancer by tumor heterogeneity exploitation

J Weiße, J Rosemann, L Müller, M Kappler, AW Eckert… - Molecular Cancer, 2021 - Springer
Background Cancer metastases are the main cause of lethality. The five-year survival rate
for patients diagnosed with advanced stage oral cancer is 30%. Hence, the identification of …

Targeted therapy for metastatic renal cell carcinoma

F Hofmann, EC Hwang, TBL Lam, A Bex… - Cochrane Database …, 2020 - cochranelibrary.com
Background Several comparative randomised controlled trials (RCTs) have been performed
including combinations of tyrosine kinase inhibitors (TKIs) and immune checkpoint inhibitors …

[HTML][HTML] An exploratory randomized-controlled trial of the efficacy of the Src-kinase inhibitor saracatinib as a novel analgesic for cancer-induced bone pain

S Danson, MR Mulvey, L Turner, J Horsman… - Journal of bone …, 2019 - Elsevier
Pain is a major symptom of bone metastases from advanced cancer and represents a
clinical challenge to treat effectively. Basic neurobiology in preclinical animal models …

The Lyn/RUVBL1 Complex Promotes Colorectal Cancer Liver Metastasis by Regulating Arachidonic Acid Metabolism Through Chromatin Remodeling

Z Zhang, Y Gao, Y Qian, B Wei, K Jiang… - Advanced …, 2024 - Wiley Online Library
Liver metastasis is a common cause of death in colorectal cancer (CRC) patients, but
epigenetic remodeling and metabolic reprogramming for CRC liver metastasis remain …